Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 August 2019 | Story Lacea Loader

The composition of the UFS Council is stipulated in the UFS Statute, which was published in the Government Gazette on 26 January 2018 and amended by publication in the Government Gazette on 29 March 2019.

The Convocation has to elect two (2) external (neither employees nor students of UFS) representatives to the Council to represent the Convocation and Alumni on Council, following the expiry of the term of office of these representatives.  The two (2) elected representatives will serve for a period of four years on Council.

The Convocation comprises all persons who obtained a formal qualification from the UFS, as well as all permanent academic staff members.

Members of the Convocation are invited to submit written nominations by using the Nomination Form, for the following:

1.    one representative from the Qwaqwa Campus; and
2.    one other representative.

Every nomination form shall be signed by 4 (four) members of the Convocation and shall contain the written acceptance of the nomination by the nominee under his/her signature, as well as an abridged CV and a motivation of ± 200 words.

All nominations must reach the office of the Registrar no later than 16:30 on Tuesday, 17 September 2019.

If more than one person is nominated for each of the categories mentioned above, elections will be held as stipulated in the Institutional Rules. More information regarding this process will follow at that stage.

Nominations are to be submitted to:
e-mail: registrar@ufs.ac.za

or by post (strongly advised not to use this method due to delays):

Mr NN Ntsababa  
Registrar
University of the Free State
PO Box 339
Bloemfontein
9300

or hand-delivered to:                

Mr NN Ntsababa
Room 51, 1st Floor
Main Building
UFS Bloemfontein Campus

For enquiries, please contact Mr NN Ntsababa at registrar@ufs.ac.za or +27 51 401 3796.

Kindly take note that late or incomplete nominations will not be accepted or considered.

Every nomination must be submitted separately.

News Archive

Otorhinolaryngology research hopes to decrease morbidity
2016-10-04

Description: Prof Riaz Seedat Tags: Prof Riaz Seedat

Prof Riaz Seedat, Head of the
Department of
Otorhinolaryngology at the UFS

Prof Riaz Seedat, Head of the Department of Otorhinolaryngology at the UFS is a world-renowned ear, nose and throat specialist and researcher. He is also a National Research Foundation C3 rated scientist.

He is conducting his research in ear, nose and throat (ENT) pathology in a developing world setting, particularly focusing on recurrent respiratory papillomatosis and other ENT conditions. “This condition is caused by human papillomavirus (HPV), infective conditions as well as allergic rhinitis,” said Prof Seedat.

Current research is aimed at further describing the epidemiology of recurrent respiratory papillomatosis, identification of the HPV variants responsible for causing the condition and markers of disease aggressiveness.

The research has led to various international partnerships such as the multicentre collaborative studies, “Genetic Susceptibility to Papilloma-induced Voice Disturbance” at the Centre for Genomic Sciences at the Allegheny-Singer Research Institute in Pittsburgh, United States, and the HPV6/11 Global Diversity Consortium at the University of Ljubljana in Slovenia.

Although most head and neck squamous cell carcinomas are caused by excessive tobacco and alcohol use, there is an increasing body of evidence to show that HPV causes a subset of head and neck squamous cell carcinomas. However, there are few studies on the role of HPV in head and neck neoplasms in developing countries.

“Through the research we have shown that recurrent respiratory papillomatosis, caused by HPV, is not as rare in South Africa as it is in developed countries and that patients usually present respiratory papillomatosis at an advanced stage when the condition is life-threatening,” said Prof Seedat.

“It is hoped that this research will help us to address the morbidity caused by ENT conditions common in developing countries,” said Prof Seedat.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept